What must be true about prescriptions for isotretinoin?

When considering prescriptions for isotretinoin, it is essential to understand the stringent regulations surrounding its use due to the medication's potency and potential side effects, particularly teratogenic risks associated with pregnancy. The requirement to dispense no more than a one-month supply aligns with risk management strategies established to prevent misuse and ensure patient monitoring.

Isotretinoin is often prescribed under the iPLEDGE program, which provides a framework to manage and mitigate risks, especially in female patients of childbearing age. By limiting the supply to a one-month duration, healthcare providers can closely monitor the patient's health, adherence to the prescription, and any side effects they may experience. This approach also reinforces the importance of ongoing patient education about the potential risks associated with isotretinoin, especially regarding pregnancy prevention and the need for regular follow-up appointments.

The other options do not accurately reflect the requirements for isotretinoin prescriptions. For example, isotretinoin prescriptions do not include mandatory multiple refills due to the need for continuous monitoring and risk assessment. Furthermore, isotretinoin can be filled at retail pharmacies, contrary to the suggestion that it can only be filled at mail-order pharmacies. Additionally, there is no restriction that limits prescribing exclusively to dermatologists;